Log in to your Inderes Free account to see all free content on this page.

Biohit

2.54 EUR

-0.39%

4,934 following
Corporate customer

BIOBV

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Biohit

20192020202120222023202420252026e2027e2028e2029e
Revenue10.17.19.411.013.114.315.717.018.721.224.6
growth-%-29.1 %31.4 %17.0 %19.2 %9.8 %9.6 %8.0 %10.1 %13.6 %16.0 %
EBITDA0.6-1.20.51.62.12.93.43.14.65.16.2
EBIT (adj.)-1.4-3.2-1.51.11.82.52.92.63.03.34.2
EBIT-1.4-3.2-1.51.11.82.52.92.63.03.34.2
Profit before taxes-1.2-3.3-1.30.92.22.82.92.83.23.54.4
Net income-1.4-3.3-1.50.61.82.72.72.22.62.83.5
EPS (adj.)-0.09-0.22-0.100.040.120.180.180.150.170.180.23
growth-%-134.0 %54.8 %140.1 %189.9 %53.1 %0.2 %-17.9 %15.1 %9.5 %25.5 %
Dividend0.000.000.000.000.000.000.000.040.050.060.12
Dividend ratio30.0 %30.0 %30.0 %50.0 %
Login required

This content is only available for logged in users

Profitability and return on capital

20192020202120222023202420252026e2027e2028e2029e
EBITDA-%5.9 %-16.5 %5.4 %14.7 %16.1 %19.9 %21.7 %18.4 %24.8 %24.1 %25.0 %
EBIT-% (adj.)-14.0 %-44.6 %-15.8 %10.3 %13.4 %17.1 %18.5 %15.4 %16.0 %15.5 %17.0 %
EBIT-%-14.0 %-44.6 %-15.8 %10.3 %13.4 %17.1 %18.5 %15.4 %16.0 %15.5 %17.0 %
ROE-28.3 %-18.5 %8.0 %20.6 %24.7 %19.8 %13.7 %14.0 %13.9 %15.6 %
ROI-25.9 %-17.7 %14.3 %19.1 %23.5 %18.2 %16.1 %17.5 %17.3 %19.5 %
Login required

This content is only available for logged in users